In a new study from Western Sydney University, researchers found a connection between the accumulation of rogue proteins in the eye and Alzheimer’s disease.
The finding could pave the way for an eye test to detect Alzheimer’s disease long before it damages the brain.
In the study, the team produces unique antibodies to detect rogue proteins called ‘amyloid-beta oligomer.”
While scientists already know these rouge proteins can be detected as much as two decades before the onset of Alzheimer’s disease, this is the first time they have been detected in the eye before clinical disease and brain damage have ensued.
The team says this could lead to a better understanding of Alzheimer’s disease and new diagnostic approaches which could enable the first routine eye check for Alzheimer’s disease.
Alzheimer’s disease has reached epidemic proportions and represents a substantial health burden, affecting the quality of life of millions of patients and their families.
Introducing these routine eye-checks that could catch the disease before it impacts the brain could change the lives of millions.
If you care about Alzheimer’s disease, please read studies about this beverage may benefit people with earliest Alzheimer’s disease and findings of this thing may contribute to cognitive decline in Alzheimer’s.
For more information about Alzheimer’s disease treatment and prevention, please see recent studies about Alzheimer’s may show its hint 40 years before it starts and results showing that this gum disease may determine whether you will have Alzheimer’s.
The study is published in Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring. One author of the study is Associate Professor Mourad Tayebi.
Copyright © 2021 Knowridge Science Report. All rights reserved.
